Constronics (523844)
TurnaroundScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹76.8 |
| Market Cap | ₹96.22 Cr |
| P/E Ratio | 24.25 |
| ROCE | 0% |
| ROE | 13.49% |
| Dividend Yield | 0% |
| Profit Growth | -67.71% |
| Debt/Equity | — |
| Sales Growth | -42.97% |
| 52-Week Range | ₹40.7 — ₹76.8 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹22.02 |
Strengths
- Trailing ROE of 13.49% shows the company has delivered reasonable returns on book equity historically.
- Book value of ₹22.02 per share offers tangible asset backing, even though the market price is far above it.
- Still profitable on trailing earnings: P/E of 24.25 implies roughly ₹4 crore net profit on a ₹96 crore market cap.
- Latest quarter sales of ₹9 crore show the distribution operation is still functioning, though with zero profit.
Concerns
- Revenue and profit are collapsing: sales down 42.97% and profit down 67.71%; latest quarterly net profit is ₹0 crore.
- Piotroski F-Score of 2/9 indicates very weak financial health and likely deteriorating balance-sheet quality.
- No return on capital employed (ROCE 0.00%) and zero dividend, so shareholders get no current return.
- Valuation is expensive relative to fundamentals: P/E 24.25, P/B 3.49, and price at 52-week high despite shrinking earnings.
AI Analysis
Let me start with what I see: a ₹96 crore market cap, a price of ₹76.80, and a book value of just ₹22.02. That means the market is asking me to pay more than 3.5 times stated assets for a trading and distribution company. In my experience, distributors rarely deserve such a premium. There is no brand, no pricing power, and no lasting moat. The numbers confirm my unease. Sales have fallen by 42.97%, profits by 67.71%, and the latest quarter's net profit is essentially zero on ₹9 crore of sales. A Piotroski score of 2 out of 9 signals a business that is financially stressed, not one that is strengthening. The trailing ROE of 13.49% looks decent, but it is backward-looking and probably unsustainable if current trends continue. ROCE at 0.00% reinforces my worry; the company is not earning an acceptable return on the capital it deploys. At ₹76.80, the stock is also at the upper end of its 52-week range. So I am being asked to pay top dollar for deteriorating operations. The P/E of 24.25 may look reasonable for a growing franchise, but this is not growing; it is shrinking. Dividend yield is zero, so there is no income support while I wait. If I owned this, I'd be asking management to explain the decline and show a clear path back to profitability. As a value investor, I need a margin of safety. Here, the price offers no such margin; it offers hope. Hope is not an investment strategy. In Benjamin Graham's language, this is speculative. I would pass until the fundamentals, not just the price, turn up.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer